Ditchcarbon
  • Customers
  1. Organizations
  2. Vericel Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Vericel Corporation

Company website

Vericel Corporation, a leading player in the regenerative medicine industry, is headquartered in the United States. Founded in 1989, the company has made significant strides in developing innovative cell-based therapies, particularly for patients with severe skin injuries and cartilage damage. Vericel's core products, including Epicel® and MACI®, are distinguished by their ability to harness the body’s own cells to promote healing, setting them apart in the competitive landscape of advanced therapeutics. With a strong presence in the US and expanding operations in key international markets, Vericel has established itself as a pioneer in the field. The company’s commitment to research and development has led to notable achievements, including FDA approvals that underscore its market position. Vericel continues to drive advancements in regenerative medicine, aiming to improve patient outcomes and redefine treatment paradigms.

DitchCarbon Score

How does Vericel Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Vericel Corporation's score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Vericel Corporation's reported carbon emissions

Vericel Corporation, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, as indicated by the absence of specific emissions figures. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. As of now, Vericel Corporation does not inherit emissions data from any parent company, nor does it have any specific commitments to the Science Based Targets initiative (SBTi) or other climate-related frameworks. This lack of data and commitments suggests that Vericel may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, it is increasingly important for companies to establish clear emissions reduction targets and transparent reporting practices to align with global climate goals. Without specific emissions data or commitments, Vericel Corporation's climate impact remains unclear.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vericel Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vericel Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vericel Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Integra lifesciences

US
•
Health and social work services (85)
Updated 3 days ago

Osiris Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

BioRestorative Therapies, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

MiMedx Group, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Exactech, Inc.

US
•
Health and social work services (85)
Updated 12 days ago

Orthofix

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250806.6
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy